Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center
FOUNDED
2013
DIRECTOR
James Brugarolas, M.D., Ph.D.
PROGRAM HIGHLIGHTS
- One of the largest kidney cancer programs in the world
- Survival rates that double national benchmarks for Stage 4 patients and improved across stages
- Development of first-in-class HIF2 inhibitor drug, going from gene discovery to FDA approval in 2021
- One of only two programs in the U.S. developing immunotherapies with a Nobel Prize-winning immunologist
- Largest and most innovative radiation oncology program pioneering new applications
- One of the first to develop kidney tumor ablation programs in U.S.
- First molecular classification – setting foundation for precision medicine approaches
- Largest robotic kidney surgery program in North Texas
- Founding member of the first national Kidney Cancer Clinical Trials Network
- National research hub
EXPERTISE
- 120+ physicians and scientists
- 18 research tracks
RECOGNITION
- Specialized Program of Research Excellence Award, National Cancer Institute
- Inaugural Healthcare Innovation Award Finalist, D CEO Magazine
- Leaders in Clinical Excellence Program Award, UT Southwestern Medical Center
SPECIALIZATIONS
- Clinical Genetics
- Medical Oncology
- Pediatric Oncology
- Pediatric Urology
- Radiation Oncology
- Subspecialty Pathology
- Subspecialty Radiology
- Urology
RESEARCH FUNDING (2013 - PRESENT)
>$120 million
FOUNDATION
UT Southwestern Medical Center
Ranked No. 1 globally for health care research by Nature Index
- 6 Nobel Laureates
- 26 National Academy of Sciences members
- 20 National Academy of Medicine members
- 14 Howard Hughes Medical Institute Investigators
Harold C. Simmons Comprehensive Cancer Center
- One of 56 comprehensive cancer centers designated by the National Cancer Institute in the U.S. and the only one in North Texas
- One of only 33 National Comprehensive Cancer Network centers
